Y. Bergman and R. Mostoslavsky, DNA demethylation: turning genes on, Biol. Chem, vol.379, pp.401-407, 1998.

J. K. Christman, 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy, Oncogene, vol.21, pp.5483-5495, 2002.

M. Esteller, CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future, Oncogene, vol.21, pp.5427-5440, 2002.

M. Frommer, L. E. Mcdonald, D. S. Millar, C. M. Collis, F. Watt et al., A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands, Proc. Natl. Acad. Sci. USA, vol.89, pp.1827-1831, 1992.

T. Guillaudeux, A. M. Rodriguez, M. Girr, V. Mallet, S. A. Ellis et al., , 1995.

, Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta, J. Immunol, vol.154, pp.3283-3299

C. Hanski, E. Riede, A. Gratchev, H. D. Foss, C. Bohm et al., MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation, Lab. Invest, vol.77, pp.685-695, 1997.

M. P. Herman, G. K. Sukhova, W. Kisiel, D. Foster, M. R. Kehry et al., Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis, J. Clin. Invest, vol.107, pp.1117-1126, 2001.

F. Hubé, P. Reverdiau, S. Iochmann, S. Trassard, G. Thibault et al., Demonstration of tissue factor pathway inhibitor-2 (TFPI-2) mRNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas, Biol. Reprod, vol.68, pp.1888-1894, 2003.

F. Hubé, P. Reverdiau, S. Iochmann, C. Cherpi-antar, and Y. Gruel, Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line, Thromb. Res, vol.109, pp.207-215, 2003.

S. Iochmann, P. Reverdiau-moalic, F. Hubé, P. Bardos, and Y. Gruel, Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR, Thromb. Res, vol.105, pp.217-223, 2002.
URL : https://hal.archives-ouvertes.fr/hal-02127753

M. Jin, K. Udagawa, E. Miyagi, T. Nakazawa, F. Hirahara et al., Expression of serine proteinase inhibitor PP5/ TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo, Gynecol. Oncol, vol.83, pp.325-333, 2001.

H. Kinoshita, Y. Shi, C. Sandefur, L. F. Meisner, C. Chang et al., Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer, Cancer Res, vol.60, pp.3623-3630, 2000.

S. D. Konduri, A. Tasiou, N. Chandrasekar, G. L. Nicolson, and J. S. Rao, Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion, Clin. Exp. Metastasis, vol.18, pp.303-308, 2000.

S. D. Konduri, C. N. Rao, N. Chandrasekar, A. Tasiou, S. Mohanam et al., A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion, Oncogene, vol.20, pp.6938-6945, 2001.

S. S. Lakka, S. D. Konduri, S. Mohanam, G. L. Nicolson, and J. S. Rao, In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2, Clin. Exp. Metastasis, vol.18, pp.239-244, 2000.

Y. Miyagi, H. Yasumitsu, T. Eki, S. Miyata, N. Kkawa et al., Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis, Genomics, vol.35, pp.267-268, 1996.

C. N. Rao, B. Cook, Y. Liu, K. Chilukuri, M. S. Stack et al., HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI, Int. J. Cancer, vol.76, pp.749-756, 1998.

C. N. Rao, S. Mohanam, A. Puppala, and J. S. Rao, Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor, Biochem. Biophys. Res. Commun, vol.255, pp.94-98, 1999.

C. N. Rao, S. S. Lakka, Y. Kin, S. D. Konduri, G. N. Fuller et al., Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas, Clin. Cancer Res, vol.7, pp.570-576, 2001.

R. Singal, R. Ferris, J. A. Little, S. Z. Wang, and G. D. Ginder, Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells, Proc. Natl. Acad. Sci. USA, vol.94, pp.13724-13729, 1997.

C. A. Sprecher, W. Kisiel, S. Mathewes, and D. C. Foster, Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor, Proc. Natl. Acad. Sci. USA, vol.91, pp.3353-3357, 1994.